Filing Details
- Accession Number:
- 0001144204-15-016825
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-17 18:43:01
- Reporting Period:
- 2015-03-13
- Filing Date:
- 2015-03-17
- Accepted Time:
- 2015-03-17 18:43:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1598646 | Minerva Neurosciences Inc. | NERV | Pharmaceutical Preparations (2834) | 260784194 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
200406 | Johnson & Johnson | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | No | No | Yes | No | |
924020 | Johnson & Johnson Innovation - Jjdc, Inc. | 410 George Street New Brunswick NJ 08901 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-13 | 607,903 | $4.81 | 4,500,159 | No | 4 | P | Indirect | By Johnson & Johnson Innovation - JJDC, Inc. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Johnson & Johnson Innovation - JJDC, Inc. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants (right to buy) | Acquisiton | 2015-03-13 | 607,903 | $0.13 | 607,903 | $5.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
607,903 | 2015-03-18 | 2017-03-18 | No | 4 | P | Indirect |
Footnotes
- The transaction is subject to customary closing conditions and is expected to close on or about 03/18/2015.
- Consists of 3,892,256 shares of Common Stock and 607,903 shares of Common Stock underlying immediately exercisable warrants.
- The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person (formerly known as Johnson & Johnson Development Corporation).